Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999710 | Urologic Oncology: Seminars and Original Investigations | 2015 | 7 Pages |
Abstract
Our study is among the first to report an association between metformin use and improved RFS and BCSS in diabetic patients undergoing RC. Given its low cost and demonstrated safety among nondiabetic patients, further studies are warranted to evaluate potential therapeutic and preventive roles of metformin in BC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Madhur M.D., C.M., Bimal M.D., C.M., M.Sc., Julie L. M.D., Thomas M.D., Aza M.B.Ch.B., Robert J. M.D., M.P.H., Antonio M.D., M.Sc., Michael A.S. M.D., Alexandre R. M.D., Ph.D., Neil E. M.D., M.P.H., Girish S. Kulkarni,